Search EdNeuro Page
Search EdNeuro Page
The search found 29 results in 0.033 seconds.
Professor Malcolm Macleod (Centre for Clinical Brain Sciences) and Jeffrey Mogil (McGill University, Montreal) propose a new approach to animal studies, in order to address the concern over the reliability and reproducibility of such studies.
Dr Veronique Miron (Centre for Reproductive Health) and colleagues have published a study showing that a specific molecule in the brain is fundamental to repairing the damage caused in Multiple Sclerosis.
On Wednesday 28 June 2017, members of the University of Edinburgh's Stroke Research Group (SRG), both past and present, gathered to celebrate 30 years of stroke research in Edinburgh. There was an excellent turn out for the celebration, including Professor Emeritus Charles Warlow, and Peter Sandercock presented a nostalgic walk down memory lane before cutting the cake.
Huge congratulations to Professor Rustam Al-Shahi Salman, Professor Colin Smith, Dr Emily Sena and Dr Grant Mair (all Centre for Clinical Brain Sciences) who each received an award at the Stroke Association Annual Awards Ceremony on the 2nd of May!
The Centre for Clinical Brain Sciences (CCBS) was profiled in The Lancet, in an article outlining the structure and research focus of the Centre.
Professors Joanna Wardlaw (Centre for Clinical Brain Sciences, University of Edinburgh), Karen Horsburgh (Centre for Neuroregeneration, University of Edinburgh) and Rhian Touyz (Institute of Cardiovascular & Medical Sciences, University of Glasgow) are guest editors on the recently released Clinical Science special edition on small vessels, dementia & chronic disease.
Dr Susan Shenkin (Centre for Clinical Brain Sciences, Geriatric Medicine, and Centre for Cognitive Ageing & Cognitive Epidemiology) who has been named as clinical lead for Ageing for NHS Research Scotland.
Dr Will Whiteley (Stroke Research Group, Centre for Clinical Brain Sciences) has been awarded a prestigious Scottish Senior Clinical Fellowship from the Chief Scientist Office to study the contribution of vascular risk factors to dementia.
Professor Brian Walker, Professor Jonathan Seckl and Dr. Scott Webster (all Centre for Cardiovascular Sciences) have developed a drug, Xanamem, that has just entered Phase II clinical trials and been administered to the first patient by Actinogen Medical in Australia.